title: Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.
authors.affiliation: Department of Pediatrics, Seattle Children's Research Institute and University of Washington, Seattle, WA 98101, USA. miao@u.washington.edu
authors.forename: C H
authors.initials: CH
authors.lastname: Miao
mesh_terms: D000818:Animals; D000906:Antibodies / Q000097:blood*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D003029:Coagulants / Q000008:administration & dosage*; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage*
chemical_list: D000906:Antibodies; D003029:Coagulants; D007166:Immunosuppressive Agents; C078147:F8 protein, human; D005169:Factor VIII; D020123:Sirolimus